Smith Nicholas Conrad sold ANRO
September 30, 2026 · Form 4 insider transaction
Smith Nicholas Conrad sold 886 shares of Alto Neuroscience, Inc. at $26.87 per share, a transaction worth $23.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
886
Price
$26.87
Total value
$23.8K
InsiderSmith Nicholas Conrad
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 30, 2026
Filing dateOctober 1, 2026
Shares owned after24,060
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 30, 2026.